Company: PSTV
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0000950170-25-047698
Chunk: 182

Company: PLUS THERAPEUTICS, INC.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 8
Chunk 182
---
 Company. As of December 31, 2024, there were 62,908 shares of common stock remaining and available for future issuances under the 2015 Plan.  The Company’s 2020 Stock Incentive Plan (the “2020 Plan”), which replaced the Company’s 2014 Equity Incentive Plan, provides for the award or sale of shares of common stock (including restricted stock), the award of stock units and stock appreciation rights, and the grant of both incentive stock options to purchase common stock to directors, officers, employees and consultants of the Company. The 2020 Plan, as amended, provides for the issuance of up to 3,550,000 shares of common stock, plus the number of shares available for issuance is increased to the extent that awards granted under the 2020 Plan and the Company’s 2014 Equity Incentive Plan are forfeited or expire (except as otherwise provided in the 2020 Plan). As of December 31, 2024, there were 692,596 shares remaining and available for future issuances under the 2020 Plan.Generally, options issued under the 2020 Plan are subject to a two-year or four-year vesting schedule with 25% of the options vesting on the one year anniversary of the grant date followed by equal monthly installment vesting, and have a contractual term of 10 years.            A summary of activity for the year ended December 31, 2024 is as follows: 

        Options

        Weighted Average Exercise Price

        WeightedAverageRemainingContractualTerm (years)

        AggregateIntrinsic Value

        Balance as of December 31, 2023

        140,109

        $
        37.48

        8.07

        Granted

        506,127

        1.58

        Cancelled/forfeited

        (47,696
        )

        38.02

        Balance as of December 31, 2024

        598,540

        $
        7.08

        9.00

        $
        -

        Vested and expected to vest at December 31, 2024

        547,893

        $
        7.52

        9.00

        $
        -

        Exercisable at December 31, 2024

        144,739

        $
        22.96

        7